Evidence map›Paper›PMID 42756769›Full record

ArticleFrontiers in pharmacology2026

Targeting skin aging: anti-senescent potential and key enzyme modulation of

Jorge M Alves-Silva, Joana Domingues, Fernanda Delgado, Teresa Ribeiro, Teresa Cruz, Lígia Salgueiro, Henrique Girão, Mónica Zuzarte

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jorge M Alves-SilvaCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Joana DominguesPlant Biotechnology Centre of Beira Interior (CBPBI), Castelo Branco, Portugal.
Fernanda DelgadoPolytechnic University of Castelo Branco-School of Agriculture (IPCB-ESA), Castelo Branco, Portugal.
Teresa RibeiroCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Teresa CruzCenter for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
Lígia SalgueiroFaculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Henrique GirãoCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Mónica ZuzarteCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Skin aging is an inherent biological process linked to chronological aging that can be accelerated by external factors. Cellular senescence and skin enzymes are crucial players in this process and, therefore, relevant preventive and therapeutic targets. In this scenario, aromatic plants and their essential oils have gained attention as promising agents in the management of skin aging. The present study aims to explore the anti-senescent potential of Methods: The chemical characterization of the essential oils was carried out by gas chromatography-mass spectrometry and their effect evaluated on etoposide-induced senescent fibroblasts during the recovery phase. Relevant markers of cellular senescence were analyzed, namely, β-galactosidase activity through a colorimetric assay, nuclear alterations by immunofluorescence, SASP secretion through ELISA, expression levels of cell cycle inhibitors by WB analysis and ultrastructural alterations using transmission electron microscopy. Modulation of key enzyme activity was determined using an Results: The essential oil of Conclusion: These results highlight the potential of

Indexed as

collagenasefibroblastslavendersnatural productssenotherapeutic

Identifiers

PMID42756769
PMCPMC13583431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.